🔥 Concentrated Flow (Market Close)
See full theme ranking and leading stocks →
Diabetes Stocks and Leader (Korea)
Updated: 2026.10.30 (market close)
The Diabetes theme has 10 member stock(s) today, with an average return of -3.3%. The leading stock is 아이센스 (+1.4%, trading value 509,642,500).
Chronic disease treatment and management market, drawing attention due to synergistic growth with obesity treatments (GLP-1) and the adoption of advanced medical devices such as Continuous Glucose Monitors (CGM).
| Stock | Price | Return | Trading Value |
|---|---|---|---|
| 아이센스 | 15,930 | +1.4% | 509,642,500 |
| 삼진제약 | 19,240 | -0.7% | 582,429,200 |
| 현대약품 | 6,590 | -1.4% | 1,932,737,445 |
| 녹십자엠에스 | 3,095 | -2.1% | 1,437,884,794 |
| 제일약품 | 8,550 | -3.2% | 56,420,445 |
| 압타바이오 | 5,070 | -4.5% | 343,137,750 |
| 안트로젠 | 13,350 | -5.2% | 552,764,190 |
| 펩트론 | 91,900 | -5.4% | 13,369,280,250 |
| 동운아나텍 | 19,000 | -5.5% | 1,453,617,250 |
| 윈팩 | 2,560 | -6.9% | 686,636,280 |
This page's data is for reference only and is not investment advice. Actual market data may differ.